As Canada’s prime minister talks up the imminent legalization of marijuana, a Vancouver-based pharmaceutical startup is taking the cannabis plant apart to find compounds that could treat disorders ranging from glaucoma to a rare skin disorder.
InMed Pharmaceuticals aims to use the more than 100 different “cannabinoids” as the raw materials for a number of clinical applications.
“We’re going far away from any so-called recreational (use),” said InMed chief medical officer Dr. Ado Muhammad. “We’re going away completely from that direction, to make sure that the product is comparable to any other antibiotics or drugs.”
– Read the entire article at Vancouver Sun.